NCT05702229 2026-03-18Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaAstraZenecaPhase 2 Recruiting163 enrolled
NCT07334431 2026-01-12Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric CancerHenan Cancer HospitalPhase 1/2 Recruiting45 enrolled